Evidence map›Paper›PMID 41515772›Full record

ArticleMaterials (Basel, Switzerland)2025

Influence of a Silane Coupling Agent and MWCNTs on the Structural and Durability Performance of CFRP Rebars.

Woo Sung Yum, Do Young Kwon, Yong Sik Chu

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Woo Sung YumClimate and Energy Research Division, Research Innovation Headquarters, Korea Institute of Ceramic Engineering & Technology (KICET), 101, Soho-Ro, Jinju 52851, Republic of Korea.ORCID 0000-0003-0845-1511
Do Young KwonClimate and Energy Research Division, Research Innovation Headquarters, Korea Institute of Ceramic Engineering & Technology (KICET), 101, Soho-Ro, Jinju 52851, Republic of Korea.
Yong Sik ChuClimate and Energy Research Division, Research Innovation Headquarters, Korea Institute of Ceramic Engineering & Technology (KICET), 101, Soho-Ro, Jinju 52851, Republic of Korea.ORCID 0000-0002-1023-528X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the influence of silane coupling agents and multi-walled carbon nanotubes (MWCNTs) on the mechanical, durability, and thermal performance of CFRP rebars manufactured using a pilot-scale pultrusion process. The incorporation of additives extended epoxy working time without causing adverse viscosity effects during processing. Silane-modified CFRP rebars exhibited the highest mechanical performance, achieving a tensile strength of approximately 2649 MPa, an elastic modulus of 156 GPa, and improved bond strength with concrete, which is attributed to enhanced fiber-matrix interfacial adhesion. MWCNT-modified rebars showed slightly lower tensile strength but demonstrated superior thermal resistance, retaining the highest proportion of mechanical properties after exposure to 250 °C due to matrix reinforcement and crack-bridging effects. No significant degradation was observed under simulated marine exposure, while gradual reductions (up to ~7%) occurred in alkaline environments, with silane-modified rebars showing the greatest durability. These findings provide mechanistic insights and practical guidelines for optimizing epoxy formulations to enhance the structural and long-term performance of CFRP rebars.

Indexed as

CFRP rebarsdurabilityepoxy matrix modificationfire resistanceMWCNT (multi-walled carbon nanotubes)silane coupling agent

Identifiers

PMID41515772
PMCPMC12786413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.